-The Hindu Civil liberties activists have criticised the media for being an IB mouthpiece in the Ishrat Jahan fake encounter case, while others question the role of ‘activist journalists' The battle over the Gujarat encounter killings of 2004 is being fought at multiple levels. An ideological and political conflict has erupted over the ways to fight "terror." The Intelligence Bureau (IB) and Central Bureau of Investigation (CBI) are engaged in an unprecedented inter-agency...

-The Times of India NEW DELHI: Union minority affairs minister Rahman Khan wants the government to form an all-powerful taskforce to monitor and review terror cases against Muslims, arguing that it is needed to ensure justice for "innocent Muslim youth" languishing in jails after being framed in terror cases. Khan cited the example of the UK which, he said, has formed a task force under Prime Minister David Cameron to ensure there...

-The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels...

-The Indian Express Two years back, 27 high-density national highway corridors were awarded amid much fanfare to developers who outbid competitors by promising to pay the government a "premium", instead of the general practice of seeking a capital grant from the Centre. Of these projects, all of which were touted as a testimony to renewed investor confidence in the roads sector, 24 sections worth a whopping Rs 34,000 crore and spanning...

-The Economic Times NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe. "At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia," a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET. The Australian...